| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | Eric Warren | Chief Commercial Officer | Aug 21, 2026 | Option/RSU Exercise | $13.24 | 7,437 | 98,466 | 45,837 | Aug 25, 2026, 05:16 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Eric Warren | Chief Commercial Officer | Aug 21, 2026 | Sale | $25.98 | 7,437 | 193,189 | 38,400 | Aug 25, 2026, 05:16 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Eric Warren | Chief Commercial Officer | Jul 21, 2026 | Option/RSU Exercise | $13.24 | 7,438 | 98,479 | 45,838 | Jul 23, 2026, 06:39 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Eric Warren | Chief Commercial Officer | Jul 21, 2026 | Sale | $26.87 | 7,438 | 199,885 | 38,400 | Jul 23, 2026, 06:39 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Eric Warren | Chief Commercial Officer | Jun 26, 2026 | Sale | $25.90 | 104,124 | 2,696,322 | 38,400 | Jun 30, 2026, 06:41 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Eric Warren | Chief Commercial Officer | Jun 26, 2026 | Option/RSU Exercise | $13.24 | 104,124 | 1,378,602 | 142,524 | Jun 30, 2026, 06:41 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More